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ABSTRACT 
As the driving population ages, the number of drivers with visual impairment resulting from 
ocular disease will increase given the age-related prevalence of ocular disease. The increase in 
visual impairment in the driving population has a number of implications for driving outcomes. 
This review summarises current research regarding the impact of common ocular diseases on 
driving ability and safety, with particular focus on cataract, glaucoma, age-related macular 
degeneration, hemianopia and diabetic retinopathy. The evidence considered includes self-
reported driving outcomes, driving performance (on-road and simulator-based) and various motor 
vehicle crash indices. Collectively, this review demonstrates that driving ability and safety are 
negatively affected by ocular disease, yet further research is needed in this area. Older drivers 
with ocular disease need to be aware of the negative consequences of their ocular condition and 
in the case where treatment options are available, encouraged to seek these earlier for optimum 
driving safety and quality of life benefits. 
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INTRODUCTION 
Driving is a complex task that involves integration of a range of visual,1 sensorimotor,2 and 
cognitive3 skills, many of which become impaired with increasing age and hence can impact on 
driving capacity, as reflected by driving ability and performance. An individual’s insight 
regarding their own driving capacity and any potential self-regulation of their driving also 
contributes to overall driving safety4 (Figure 1).  
While the number of crashes per licensed driver are highest among younger drivers, when 
these results are adjusted for driving exposure, a U-shaped curve is evident with an increase in 
injurious crash rates per kilometre travelled for older drivers.5 Importantly, the number of older 
drivers is projected to increase, based on population6 and licensing data7 (Figure 2), increasing 
numbers of whom will have age-related ocular disease. This has implications for driving ability 
and safety given that driving is considered to be a highly complex visual task. 
The increased prevalence of visual impairment with older age results both from normal age-
related visual changes, as well as the age-related increase in ocular disease. This review will 
focus on the more common ocular diseases in older adults, including cataracts, glaucoma and 
age-related macular degeneration,8 as well as other ocular conditions including hemianopia and 
diabetic eye disease that are likely to impact on driving ability and safety. Our aim is to present 
an overview of the often divergent evidence available in the current literature linking ocular 
disease and driving ability and safety.  We include studies involving self-reported driving 
difficulties, driving performance measured in simulators and under real road conditions and 
motor vehicle crash (MVC) data. As stated in a recent overview,9  it is important to be aware that 
the different methodologies used to assess driving outcomes in the vision and driving literature 
provide different information that is not necessarily interchangeable. It is thus imperative to 
account for these differences when drawing conclusions and making inferences based on the 
collective results of various studies.  
CATARACTS 
Cataracts are one of the leading causes of reversible visual impairment in older adults, with 
an estimated 30 per cent of the older population having significant cataract in at least one eye.10 
Cataract extraction is one of the most common surgical procedures worldwide, however, many 
people live with cataracts for extended periods before cataract removal,11 with around a quarter of 
these continuing to drive, even if their vision does not meet the visual standard for driving.12,13 
This has important ramifications for driving safety, given growing evidence that older drivers 
with cataracts are less safe to drive than their counterparts without cataracts.   
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Figure 1. Schematic representation of the factors determining driving safety (Adapted from 
Anstey et al4) 
 
 
 
 
Figure 2. Projected number of drivers aged 65 years and over from 2015 to 2045 in New 
South Wales, Australia. Estimates are based on population projections using current trends 
in fertility, life expectance and migration6 and current age specific rates of licensing.7 
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Drivers with cataracts report increased driving difficulties, drive shorter distances and less 
often and avoid challenging driving situations, including driving in the rain, peak hour driving 
and at night.11,14 ,15 Older drivers with cataracts who self-regulate their driving have been shown 
to have poorer contrast sensitivity in their worse eye and significantly worse depressive symptom 
scores than those who did not.15  
Despite limiting their driving exposure, drivers with cataracts have 2.5 times more at-fault 
MVC than age-matched controls without cataracts,11 and those with a history of MVC 
involvement were eight times more likely to have severe loss of contrast sensitivity in the worse 
eye (Pelli-Robson score of 1.25 or less).16 These findings are supported by studies of driving 
performance on either the closed or open road, which have shown that drivers with either 
simulated, 17,18 or true cataracts, 19-21  have impaired driving performance compared to controls.  
The impact of cataract surgery on driving outcomes has been explored in a number of 
studies, demonstrating a positive impact on a range of driving-related outcomes.  A meta-analysis 
suggested that cataract surgery was associated with a 88% reduction in the risk of driving-related 
difficulties.22  Examples of the specific aspects of driving that have been shown to improve 
following cataract surgery include driving in the rain, alone, turns across traffic and night 
driving.23  These self-reported driving difficulties were significantly reduced following first eye 
surgery in those with bilateral cataracts and these were associated with contrast sensitivity rather 
than visual acuity. Consistent with these findings, closed road driving performance improved 
significantly following bilateral cataract surgery, both after first and second eye surgery, with the 
improvement being best predicted by change in better eye contrast sensitivity.24  
Research has demonstrated a 50% reduction in crash rates for cataract patients following 
surgery, compared to those who did not have surgery.25 Furthermore, a retrospective analysis of a 
large population-linked database demonstrated that first eye cataract surgery reduced MVC risk 
by 13% in the year following surgery with savings of $4.3 million.26 Interestingly, when the data 
were analysed as a function of gender, it was demonstrated that cataract surgery was more 
effective at reducing crash risk in males than females;27 this difference may be explained by the 
fact that females tend to self-restrict their driving to a greater extent than males.28 A simulation 
model based on US data examined the impact on MVC and associated consequences of 
performing cataract surgery when self-reported symptoms are at an earlier rather than later stage. 
29  The model suggested that MVC risk is reduced by 21% for earlier surgery, with a net saving of 
16% (surgery costs balanced against crash costs), with a 5% increase in quality adjusted life 
years.29 While these findings are important in providing an indication of the potential functional 
benefits of earlier cataract surgery, they are based on a simulation model, and thus this issue 
needs to be explored in future studies.  
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Collectively, these driving outcome studies provide evidence that cataract surgery can 
provide tangible benefits to road safety, and should be targeted at an earlier rather than a later 
stage to maintain safe driving and quality of life in older adults.  However, how much earlier 
cataract surgery should be performed is unclear given that surgery is always associated with some 
degree of risk. Future studies should explore the benefits of second eye surgery as well as earlier 
surgery on driving ability and safety. In addition, identification of those patients whose driving 
performance would most benefit from cataract surgery would be very useful for informing 
surgical decisions. 
GLAUCOMA 
Glaucoma is a leading cause of visual field loss in older adults,30 affecting approximately 
60 million people worldwide, with the numbers estimated to increase significantly as the 
population ages.31 32 Importantly, 20% of those with glaucoma experience progressive visual field 
loss despite receiving appropriate treatment,33 and even in developed countries, half of those with 
glaucoma are unaware that they have the disease.34 This lack of awareness is of concern in the 
context of driving, given that older drivers are unlikely to self-regulate their driving if they are 
unaware that they have a visual problem.  
Glaucoma has been associated with a number of self-reported driving difficulties, including 
problems with glare, driving at night and tasks requiring peripheral vision and visual search.35 
Self-reported driving ability is also reduced in drivers with glaucoma.36 37 Drivers with glaucoma 
report avoiding challenging driving situations, 38  which is associated with reduced prevalence of 
self-reported crashes in men but not women.39  Importantly, glaucoma is cited as one of the main 
reasons that older drivers cease driving,40 with one study reporting that those with bilateral 
glaucoma were almost three times more likely to cease driving than those without glaucoma.41  
The driving performance of drivers with glaucoma has been compared to that of age-
matched controls in both simulator and on-road assessments. Driving simulator studies have 
generally included only small samples of drivers (generally between 20-40 drivers) with often 
conflicting results. A study of glaucoma patients with mild to moderate visual field loss showed 
that the drivers with glaucoma had significantly more simulator crashes but not more self-
reported real world crashes than controls, which were predicted by reductions in contrast 
sensitivity.42 However, a study by the same research group that included a larger sample of 
glaucoma patients with a wider range of field loss, 43 showed that the drivers with glaucoma had 
more self-reported and simulator crashes than controls and these were significantly related to the 
extent of the peripheral visual field. Similarly, a recent case control study, reported that patients 
with advanced glaucoma (Mean Defect worse than -12dB in both eyes) had significantly more 
simulator crashes in some driving scenarios which was related to integrated visual field 
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sensitivity, 44  however, the drivers were not required to operate the steering wheel or the brake. 
In another small scale simulator study, drivers with glaucoma made more steering actions, and 
were worse on the detection task than controls but there were no other between group 
differences.45 It should be noted, however, that there was no possibility of compensating for 
visual impairment in this study by reducing driving speeds as speed was fixed. Finally, 
performance on a divided attention reaction time task in a simulator study has also been reported 
to be linked with self-reported crashes in glaucoma patients,46 however, it should be noted that 
the reliability of self-reported crashes has been called into question,47 and the real world validity 
of the divided attention task was limited. 
This lack of consensus regarding the impact of glaucoma on driving simulator performance 
may arise in part from the small sample sizes. In addition, many of the simulators are dynamic 
visual detection tasks, where participants are simply required to respond to the appearance of 
various hazards by pressing a brake pedal, rather than actually driving and there is no opportunity 
to potentially compensate for visual impairment by slowing down or undertaking compensatory 
head and eye movements. 
The specific nature of the on-road driving difficulties of drivers with glaucoma has not been 
extensively studied and consists of two small-scale studies to date.  On-road assessment of 27 
glaucoma patients with binocular field loss revealed problems with lane-keeping, negotiating 
curves and anticipatory skills.48 Haymes et al.49 in a study of 20 drivers with mild to moderate 
glaucomatous loss, reported that the drivers with glaucoma were six times more likely than 
controls to have a driver instructor intervention, related to difficulties with detection of peripheral 
obstacles and hazards and unexpected events.   
Numerous studies have investigated the MVC of drivers with glaucoma, compared to either 
age-matched control drivers or with those with different levels of field loss. The experimental 
design of many of these studies has been of variable quality, with some earlier studies that 
reported elevated MVC in drivers with glaucoma,50,51 failing to adjust for confounding factors 
(including comorbid medical conditions and driving exposure).  More recent studies have 
supported these earlier studies, again showing that glaucoma is an important risk factor for MVC. 
Self-reported MVC over the previous 10 years were significantly higher only in those with severe 
glaucomatous field loss compared to controls.52  
A range of study designs involving state-recorded MVC have also reported varying levels 
of increased MVC risk in those with glaucoma.53-56  Owsley et al54 reported that drivers involved 
in an injurious crash were 3.6 times more likely to have glaucoma than those who were crash 
free.  A small scale MVC study involving both self- and police-reported crashes showed that 
drivers with glaucoma were six times more likely to have a crash than controls, with the 
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propensity for crashing being associated with impairment of the useful field of view.55 McGwin 
et al53 also reported that patients with moderate or severe glaucomatous field loss were six times 
more likely to have an at-fault crash than those with no field loss. Recent studies also confirm 
that it is only those drivers with more severe glaucomatous loss that demonstrate elevated MVC 
rates, where drivers with severe binocular Pattern Deviation defects (value worse than -3.97dB 
averaged across the integrated field) had more than double the risk of at fault MVC than those 
with less severe field impairment,56 and a recent population study reported that the elevation in 
at-fault MVC was 1.65 for all drivers with glaucoma and over 2 for those with severe field loss 
using a custom-designed ‘driving field’.57  Interestingly, no association was found between self-
reported MVC and binocular field damage,58 however, as discussed earlier in this review, self-
reported MVC are prone to reporting bias and in this study the number of patients self-reporting a 
MVC was relatively small for crash-based studies (n=51). Another observational study that 
compared the MVC risk of drivers with and without glaucoma,59 found that MVC risk was 
actually lower in those with glaucoma, however, the extent of field loss was not reported and it is 
possible that drivers with glaucoma may have compensated for their field loss by self-regulating 
their driving behaviours, and as described above, self-regulation of driving is associated with 
reduced prevalence of self-reported MVC although this was only evident in the male drivers in 
this sample.39      
Collectively, the research suggests that for glaucomatous patients, early detection is critical 
not just to minimise visual field loss but also to maintain driving performance at safe levels. 
Evidence from crash studies suggests that MVC risk generally does not increase above that of 
controls until glaucomatous loss is at moderate to severe levels and on-road studies suggest that 
lane-keeping and anticipatory skills are a particular problem. However, further studies involving 
larger numbers of participants with a range of glaucomatous loss are required to fully understand 
the specific driving difficulties associated with glaucoma. In addition, while the extent of the 
visual field appears to be associated with MVC risk, particularly when considered as the 
integrated field, the specific regions of the field that are most relevant to driving ability and safety 
requires further investigation. Importantly, patients should be advised that glaucoma can 
potentially affect their ability to drive safely given its adverse impact on peripheral visual 
function.  
AGE-RELATED MACULAR DEGENERATION  
Age-related macular degeneration (AMD) is the leading cause of irreversible visual 
impairment worldwide.60 While advances in treatment of AMD, such as anti-vascular endothelial 
growth factor injections and nutritional supplementation, may help delay or slow progression of 
some forms of the disease,61 the condition remains a leading cause of moderate to severe bilateral 
visual impairment in those aged 70 years and above.8   
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The loss of central visual function in AMD has important consequences for driving.  
Accordingly, drivers with AMD report more driving difficulties,62 and self-regulate their driving 
habits, such as avoiding challenging driving situations (night time, unfamiliar areas, rush 
hour).14,63,64  Self-reported difficulties in night driving in AMD patients have also been linked to 
reductions in rod-mediated or scotopic sensitivity.65 
The driving performance of drivers with AMD has been compared to that of age-matched 
controls in both simulator and on-road assessments.  Szlyk et al66 showed significant reductions 
in simulator driving performance of 10 drivers with AMD, including delayed braking times, 
slower speeds and more lane crossings, compared to age-matched controls. Furthermore, these 
AMD drivers showed poorer on-road driving performance, including slower speeds and poor lane 
control, than their age-matched counterparts.67  However, performance on these simulator and on-
road tests were not associated with either self- or state-reported MVCs;66 while the authors 
suggest that this finding may reflect less risk taking behaviours in this population, the findings are 
also limited due to the small sample size.  Simulator studies have also reported that pedestrian 
hazard detection rates are significantly poorer among older drivers with binocular central 
scotomas, even when appearing in the seeing areas of their visual field, compared to age-matched 
controls.68,69  
Some studies have examined associations between AMD and MVC risk.   McCloskey et 
al.50 failed to find an association between AMD and injurious crash involvement, however, they 
did not present data to indicate whether the AMD drivers had the same opportunity for crashes in 
terms of their driving exposure (typical distance travelled) as the controls.   A retrospective study 
by McGwin et al70 showed that drivers with intermediate AMD, as defined by disease grading in 
the better eye, had significantly lower MVC rates than drivers with normal vision.  The authors 
suggest that these drivers self-regulate their driving to avoid challenging situations and exercise 
greater caution on the road, which is reflected in their lower risk for MVCs.  In contrast, drivers 
with early and advanced AMD had similar MVC rates to the controls.  Drivers with early AMD 
may be less likely to self-regulate their driving, given their better levels of visual function, and 
thus show similar driving risk profiles to controls.  While it might be expected that drivers with 
advanced AMD, like those with intermediate AMD, would also self-regulate and restrict their 
driving, the study did not find reduced crash risk in this group compared to the controls.  This 
unexpected finding may be due to the low numbers of active advanced AMD drivers in the study, 
as many cease driving in the advanced stages of the condition.64 
The extent to which driving performance is affected in older drivers with AMD remains to 
be determined, given the limited number of studies that have used objective measures of driving 
performance and safety.  The paucity of data in this area, together with the increasing prevalence 
of this age-related condition, suggests that there is an important need for research to evaluate the 
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extent to which older drivers with AMD have impaired driving performance or higher crash risk 
compared with age-matched control populations and to identify strategies through which this 
population of drivers can be made safer.  
DIABETIC RETINOPATHY 
Diabetic retinopathy is a significant cause of visual impairment among working-aged and 
older adults in developed countries.71 Diabetic retinopathy can affect both central and peripheral 
vision, and is present to some degree in almost all diabetics who have had the condition for more 
than 20 years.72  Furthermore, the treatment of diabetic eye disease, such as laser 
photocoagulation, can negatively impact on visual function, resulting in visual field loss, 
impaired colour vision, contrast sensitivity and dark adaptation, and increased glare 
sensitivity.73,74  
Despite the impact of diabetic retinopathy on visual function, few studies have evaluated its 
association with driving performance and safety. A small focus group study showed that drivers 
with diabetic retinopathy, including some who had previously received laser treatment, report 
more driving difficulties especially at night,75 and driving was the sub-scale most negatively 
affected over a 10 year follow-up of patients with diabetic retinopathy.76 A small scale driving 
simulator study of 25 drivers with a range of diabetic retinopathy severity, both with and without 
prior laser treatments, demonstrated that retinal thickness and laser scarring negatively impacted 
on driving performance and increased retinal thickness was significantly related to more 
simulator crashes and near misses.77  Conversely, in the only published study investigating 
diabetic retinopathy and crash involvement, older drivers with diabetic retinopathy had similar 
risk of injurious crash involvement compared to controls.50  However, the findings must be 
interpreted with caution, as the prevalence of retinopathy, which was obtained from medical 
records, was lower in the MVC cases compared to matched controls (1.3% and 2.0%, 
respectively), and no information on the severity retinopathy or history of treatment was reported. 
Given the paucity of data in this area, it is perhaps more useful to consider the impact on 
driving safety of those specific visual functions affected in diabetic retinopathy, such as visual 
fields, contrast sensitivity and visual acuity. In addition, there have been numerous studies that 
have examined the associations between diabetes and increased crash risk with conflicting 
results.78 79 Again, as for older drivers with AMD, more research is clearly needed to understand 
more about the effect of severity, duration and treatment effects of diabetic retinopathy on driving 
performance and crash risk. 
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HOMONYMOUS HEMIANOPIA 
Homonymous hemianopic and quadrantanopic field loss, where field loss is present in one 
half or quarter of the visual field on the same side in visual space, is one of the most common 
visual impairments resulting from stroke.80 Individuals with hemianopic or quadrantanopic field 
defects, regardless of the cause or prognosis, are prohibited from licensure in many jurisdictions 
around the world. While there are no published reports of the MVC risk of individuals with 
hemianopic field defects, a number of studies have assessed driving performance in individuals 
with homonymous field loss either in simulators or under on-road conditions.   
A number of small sample simulator studies have explored the driving characteristics of 
drivers with hemianopic field loss. Higher numbers of lane crossings and greater variability in 
lane position were reported in one early study, 81 which was supported to some extent by a more 
recent study that also showed greater lane variability in the hemianopic drivers compared to 
controls but also showed that the hemianopic drivers adopted a lane position towards their seeing 
field, therefore providing a safety margin on their blind side.82 Pedestrian detection was also 
shown to be reduced in hemianopic participants compared to controls when the pedestrians 
appeared in the blind field,83 however, the pedestrians in this task were somewhat unrealistic 
(appearing abruptly and remaining stationary). A more recent study by the same authors,84  used a 
different simulator scenario that included stationary and moving pedestrians and demonstrated 
that while detection was low on the blind-side for the hemianopes, miss rates were less for 
moving pedestrians but reaction times were still longer. Two recent studies also suggested that 
some hemianopic participants demonstrate compensatory head movements in the direction of 
their non-seeing field that enable them to detect pedestrians in their blind field,85 and in another 
study the same strategy enabled some hemianopic drivers to detect potential collisions in their 
blind field in a virtual intersection task.86 
Only a limited number of studies have explored the actual driving performance of those 
with hemianopic or quadrantanopic field defects.  Tant et al87 reported problems with on-road 
steering stability in a small group of patients with homonymous hemianopia, reporting that only 
14% passed a driving assessment similar to the road test used by the local licensing authority. 
However, this study specifically recruited hemianopes whose driving was considered to be unsafe 
by the carer or patient themselves. A retrospective review of on road driving assessments, 
including a subgroup of drivers with hemianopia or quadrantanopia found that some drivers with 
hemianopic loss and all of those with quadrantanopic loss had the potential for safe driving. 88 
Similarly, a recent study reported that some drivers with hemianopic and quadrantanopic field 
defects have safe driving skills that were indistinguishable from those of drivers with normal 
fields.89 Importantly, those persons with hemianopic and quadrantanopic defects rated as safe to 
drive made more head movements into their blind field, in accord with the simulator studies 
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reported above, combined with more stable lane keeping and less sudden braking than those rated 
as unsafe to drive.90  A recent on-road study which included quantitative measurement of eye 
movements, also found that a number of the drivers, despite their hemianopic field loss, were 
rated as safe to drive (6 out of 10), with poor lane keeping being cited as the main problem with 
the unsafe drivers.91 This study also demonstrated that the safe drivers were able to compensate 
for their field defect by more extensive head and shoulder movements and more eye scans into 
their blind field.  
Collectively, research from on-road and simulator driving performance may seem 
somewhat at odds. Both suggest that lane keeping and steering control are a problem for drivers 
with hemianopia. In terms of driving safety, however, the results are apparently discordant, where 
simulator studies suggest unsafe driving, particularly in terms of the capacity to detect pedestrians 
in the blind field, while on-road studies suggest that many drivers with hemianopic field loss are 
able to drive safely, potentially through compensatory head and eye movements. It is important to 
recognise that in many senses these studies may be measuring different constructs and small 
sample studies are always limited because of the inherent heterogeneity in driving particularly in 
individuals with extensive visual impairment. However, an important limitation of many of these 
simulator studies is that because safety isn’t an issue, many of the participants are not current 
drivers and thus are unlikely to be as skilled as those who are current drivers (assuming that 
simulator driving reflects real-world driving), with whom visually impaired drivers are compared. 
The link between performance on a driving simulator and that on real roads under in-traffic 
conditions has also been called into question and requires further exploration.9  
Further research is required to further evaluate driving performance in this population using 
larger sample sizes to confirm the findings of these small sample studies and in particular, to 
determine whether characteristics such as compensatory head and eye movements could be 
trained in rehabilitation programs aimed at improving driving safety in this population.  
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CONCLUSIONS 
There is a growing body of evidence to suggest that the presence of ocular disease is 
associated with a range of driving-related difficulties, including self-reported driving problems, 
on-road and simulator-based driving performance, as well as crash risk. Collectively, the studies 
discussed in this review suggest that different ocular diseases have differential effects on driving 
ability and safety.  One of the problems for older drivers is that changes in their vision can occur 
gradually; they may thus be unaware that their vision has become impaired until a driving 
incident occurs or they are advised of visual changes following an eye examination. Importantly, 
it is unlikely that changes in visual ability relevant to driving will be detected if high contrast 
acuity continues to be used to assess visual performance for driver licensing given evidence that 
alternative vision tests including contrast sensitivity, visual field, processing speed, divided 
attention tests, and motion sensitivity are more predictive of driving ability and safety than visual 
acuity.1,92 This is an area that requires further exploration.  In addition, despite the strong 
evidence linking the presence of ocular disease and driving difficulties, further research is needed 
in order that appropriate and tailored advice can be provided to older drivers with these 
conditions.  
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